28 phenotypes from 3 alleles in 3 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Cul9em1(IMPC)Ccpcz/Cul9em1(IMPC)Ccpcz C57BL/6N-Cul9em1(IMPC)Ccpcz/Ccpcz	abnormal kidney morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	abnormal vertebrae morphology	J:211773
	abnormal vertebral arch morphology	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	increased blood urea nitrogen level	J:211773
	increased circulating creatine kinase level	J:211773
	increased circulating lactate dehydrogenase level	J:211773
	increased circulating potassium level	J:211773
	preweaning lethality, incomplete penetrance	J:211773
	vertebral transformation	J:211773
Cul9tm1.2Yxi/Cul9+ involves: 129P2/OlaHsd * C57BL/6 * FVB/N	decreased tumor-free survival time	J:170976
	increased incidence of tumors by chemical induction	J:170976
	increased insulinoma incidence	J:170976
	increased lung tumor incidence	J:170976
	increased lymphoma incidence	J:170976
	increased pituitary gland tumor incidence	J:170976
	increased sarcoma incidence	J:170976
	increased tumor incidence	J:170976
Cul9tm1.2Yxi/Cul9tm1.2Yxi involves: 129P2/OlaHsd * C57BL/6 * FVB/N	normal cellular phenotype	J:170976
	decreased body weight	J:170976
	decreased cellular sensitivity to gamma-irradiation	J:170976
	decreased cellular sensitivity to ultraviolet irradiation	J:170976
	decreased tumor-free survival time	J:170976
	increased incidence of tumors by chemical induction	J:170976
	increased liver tumor incidence	J:170976
	increased lung tumor incidence	J:170976
	increased lymphoma incidence	J:170976
	increased ovary tumor incidence	J:170976
	increased pituitary gland tumor incidence	J:170976
	increased sarcoma incidence	J:170976
	increased tumor incidence	J:170976
Cul9tm1Jdec/Cul9tm1Jdec involves: 129 * C57BL/6 * FVB/N	no abnormal phenotype detected	J:99121